Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,391 signal articles · 108 in last 24h · 115,971 total before filter · latest 27m ago
108last 24h
1731last 7d
291● bullish (7d)
158● bearish (7d)
205publishers
AllMacro315Earnings806M&A100Regulatory25Product16Analyst24
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Timken (TKR): Buy, Sell, or Hold Post Q1 Earnings?
StockStory45d agoneutral
Timken (TKR): Buy, Sell, or Hold Post Q1 Earnings?

What a fantastic six months it’s been for Timken. Shares of the company have skyrocketed 63.4%, setting a new 52-week high of $141. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Is MercadoLibre (NasdaqGS:MELI) Cheap On Cash Flow Or Too Pricey On Earnings?
Simply Wall St.45d agoneutral
Is MercadoLibre (NasdaqGS:MELI) Cheap On Cash Flow Or Too Pricey On Earnings?

MercadoLibre stock sits at an interesting valuation crossroads, with a Discounted Cash Flow (DCF) based intrinsic value estimate pointing to meaningful upside while traditional market multiples suggest the shares already trade at a premium. That split comes after a mixed share price record, including a 39.7% gain over the past 3 years but a weaker recent stretch. Over the last 3 years, MercadoLibre has returned 39.7%. This keeps the long term story intact even though shorter term performance...

How Investors Are Reacting To CVS Health (CVS) Earnings Optimism Amid New PBM Scrutiny and Care Initiatives
Simply Wall St.46d agoneutral
How Investors Are Reacting To CVS Health (CVS) Earnings Optimism Amid New PBM Scrutiny and Care Initiatives

In recent days, coverage on CVS Health has highlighted its role in America250 celebrations, expanding menopause and preventive care initiatives, and supporting Medicare obesity drug access, alongside fresh regulatory scrutiny of its Caremark pharmacy benefit manager operations. At the same time, analysts are pointing to CVS Health’s pattern of outperforming earnings estimates as a potential driver of heightened optimism around its upcoming results and near-term business performance. We’ll...